JP2009538336A5 - - Google Patents

Download PDF

Info

Publication number
JP2009538336A5
JP2009538336A5 JP2009512260A JP2009512260A JP2009538336A5 JP 2009538336 A5 JP2009538336 A5 JP 2009538336A5 JP 2009512260 A JP2009512260 A JP 2009512260A JP 2009512260 A JP2009512260 A JP 2009512260A JP 2009538336 A5 JP2009538336 A5 JP 2009538336A5
Authority
JP
Japan
Prior art keywords
group
substituted
unsubstituted
compound
glucosidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009512260A
Other languages
English (en)
Japanese (ja)
Other versions
JP5241709B2 (ja
JP2009538336A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/069448 external-priority patent/WO2007140184A2/en
Publication of JP2009538336A publication Critical patent/JP2009538336A/ja
Publication of JP2009538336A5 publication Critical patent/JP2009538336A5/ja
Application granted granted Critical
Publication of JP5241709B2 publication Critical patent/JP5241709B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009512260A 2006-05-24 2007-05-22 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法 Expired - Fee Related JP5241709B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80277606P 2006-05-24 2006-05-24
US60/802,776 2006-05-24
PCT/US2007/069448 WO2007140184A2 (en) 2006-05-24 2007-05-22 Deoxynojirimycin and d-arabinitol analogs and methods of using

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013039548A Division JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Publications (3)

Publication Number Publication Date
JP2009538336A JP2009538336A (ja) 2009-11-05
JP2009538336A5 true JP2009538336A5 (enExample) 2010-07-01
JP5241709B2 JP5241709B2 (ja) 2013-07-17

Family

ID=38779322

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009512260A Expired - Fee Related JP5241709B2 (ja) 2006-05-24 2007-05-22 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法
JP2013039548A Pending JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013039548A Pending JP2013129662A (ja) 2006-05-24 2013-02-28 デオキシノジリマイシンおよびd−アラビニトールのアナログおよび使用方法

Country Status (8)

Country Link
US (1) US8975280B2 (enExample)
EP (1) EP2023927B1 (enExample)
JP (2) JP5241709B2 (enExample)
CN (2) CN104876855A (enExample)
CA (1) CA2652958C (enExample)
ES (1) ES2537572T3 (enExample)
HK (1) HK1214261A1 (enExample)
WO (1) WO2007140184A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009545621A (ja) * 2006-08-02 2009-12-24 ユナイテッド セラピューティクス コーポレーション ウィルス感染症のリポソーム処置
CA2719567A1 (en) * 2008-03-26 2009-10-01 University Of Oxford Endoplasmic reticulum targeting liposomes
KR101755133B1 (ko) * 2009-02-23 2017-07-06 유나이티드 세러퓨틱스 코오포레이션 이미노슈가 및 바이러스성 질환을 치료하는 방법
KR20170117614A (ko) * 2009-02-24 2017-10-23 유나이티드 세러퓨틱스 코오포레이션 이미노슈가 및 아레나바이러스성 감염을 치료하는 방법
WO2010111711A2 (en) * 2009-03-27 2010-09-30 Zacharon Pharmaceuticals, Inc. Ganglioside biosynthesis modulators
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体
JP5634510B2 (ja) * 2009-06-12 2014-12-03 ユナイテッド セラピューティクス コーポレイション イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法
EP2473482B1 (en) * 2009-09-04 2014-03-05 United Therapeutics Corporation Methods of treating orthomyxoviral infections
JP5752689B2 (ja) * 2009-09-04 2015-07-22 ユナイテッド セラピューティクス コーポレイション フィロウイルス疾患を治療するイミノ糖および方法
JP5575246B2 (ja) * 2009-09-04 2014-08-20 ユナイテッド セラピューティクス コーポレイション ポックスウイルス感染の治療方法
KR20150035767A (ko) 2012-06-06 2015-04-07 유니터 바이롤로지, 엘엘씨 신규 이미노당 및 그의 용도
HK1219903A1 (zh) 2013-03-15 2017-04-21 Unither Virology, Llc 抗菌化合物
WO2014179438A2 (en) * 2013-05-02 2014-11-06 The Chancellor, Masters And Scholars Of The University Of Oxford Glycolipid inhibition using iminosugars
CA2924026C (en) 2013-09-16 2021-12-28 Emergent Virology Llc Deoxynojirimycin derivatives and methods of their using
JP6826986B2 (ja) * 2014-11-05 2021-02-10 エマージェント バイロロジー エルエルシー ウィルス性疾患の治療に有用なイミノ糖類
EP3318277A1 (en) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitors of glucosylceramide synthase for the treatment of motor neuron diseases

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
JPS54106477A (en) * 1978-02-03 1979-08-21 Nippon Shinyaku Co Ltd Moranoline derivative
JPS5943947B2 (ja) * 1978-05-03 1984-10-25 日本新薬株式会社 N−置換モラノリン誘導体
JPS5943949B2 (ja) 1978-09-29 1984-10-25 日本新薬株式会社 モラノリンのn−置換誘導体
JPS5943948B2 (ja) * 1978-07-06 1984-10-25 日本新薬株式会社 置換モラノリン誘導体
GB2020278B (en) * 1978-05-03 1983-02-23 Nippon Shinyaku Co Ltd Moranoline dervitives
DE3007078A1 (de) * 1980-02-26 1981-09-10 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
DE3024901A1 (de) 1980-07-01 1982-01-28 Bayer Ag, 5090 Leverkusen Herbizide mittel auf basis von piperidin-derivaten
DE3620645A1 (de) * 1985-12-20 1987-07-02 Bayer Ag 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
JPS62155291A (ja) 1985-12-20 1987-07-10 バイエル・アクチエンゲゼルシヤフト 3−アミノ−4,5−ジヒドロキシピペリジン類、それらの製造方法及びそれらの使用
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel
JPH0643306B2 (ja) * 1988-02-12 1994-06-08 明治製菓株式会社 癌細胞転移抑制剤
US4985445A (en) * 1988-02-12 1991-01-15 Meiji Seika Kaisha, Ltd. Cancer cell metastasis inhibitors and novel compounds
EP0350012A3 (en) * 1988-07-08 1990-09-05 Meiji Seika Kaisha Ltd. Antiviral composition
EP0367747B1 (en) * 1988-11-03 1996-03-13 G.D. Searle & Co. Dideoxy-L-arabinitol derivatives as antiviral compounds
JPH0675510B2 (ja) 1989-02-13 1994-09-28 日本新薬株式会社 モラノリン誘導体の製法
US5256788A (en) * 1989-02-13 1993-10-26 Nippon Shinyaku Co. Ltd. Moranoline derivatives and their production and the use of moranoline and its derivatives as a stabilizing agent for enzymes
US5051401A (en) * 1989-04-07 1991-09-24 University Of South Alabama Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
DE4009561A1 (de) 1990-03-24 1991-09-26 Bayer Ag Neue desoxynojirimycinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0536402A4 (en) 1990-06-29 1993-05-12 Nippon Shinyaku Company, Limited Piperidine derivative
US5290948A (en) 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
DK0739205T3 (da) 1994-01-13 2000-05-01 Searle & Co Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner
WO1995022975A1 (en) 1994-02-25 1995-08-31 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
AU753336B2 (en) 1997-11-10 2002-10-17 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
TR200002323T2 (tr) * 1998-02-12 2000-12-21 G.D. Searle & Co. Hepatit virüs enfeksiyonlarının tedavi edilmesi için N-ikameli-1,5-dideoksi 1,5-imino-D-glusitol bileşiklerinin kullanımı
GB0100889D0 (en) 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
AU2001236938A1 (en) 2000-02-14 2001-08-27 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
WO2003075916A1 (en) * 2002-03-13 2003-09-18 Van Der Spoel Aarnoud C A non-hormonal approach to male contraception
US7994198B2 (en) * 2002-07-17 2011-08-09 Actelion Pharmaceuticals Ltd. Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase
ES2572148T3 (es) * 2005-05-17 2016-05-30 Amicus Therapeutics Inc Un método para el tratamiento de la enfermedad de Pompe usando 1-desoxinojirimicina y derivados

Similar Documents

Publication Publication Date Title
JP2009538336A5 (enExample)
JP2010536766A5 (enExample)
JP2010511721A5 (enExample)
JP2004536811A5 (enExample)
JP2007511546A5 (enExample)
JP2013507423A5 (enExample)
JP2007523139A5 (enExample)
JP2010534247A5 (enExample)
IN2006DE01793A (enExample)
JP2012532135A5 (enExample)
JP2006502283A5 (enExample)
JP2010525122A5 (enExample)
MX2010003887A (es) Metodo para produicir 2?-desoxi-5-azacitidina (decitabina).
JP2010524927A5 (ja) 化合物2−ヒドロキシ−3−[5−(モルホリン−4−イルメチル)ピリジン−2−イル]1h−インドール−5−カルボニトリルの新規な製造方法
JP2005536519A5 (enExample)
DE60326819D1 (de) Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase
JP2009184932A5 (enExample)
JP2008201774A5 (enExample)
JP2012503653A5 (enExample)
JP2009541414A5 (enExample)
JP2011508779A5 (enExample)
JP2006518765A5 (enExample)
JP2004538278A5 (enExample)
JP2009522364A5 (enExample)
JP2007506664A5 (enExample)